<DOC>
	<DOCNO>NCT02579148</DOCNO>
	<brief_summary>The intent clinical study answer question : 1 ) propose treatment feasible ; 2 ) treatment effective improve disease pathology patient diagnose diabetic erectile dysfunction .</brief_summary>
	<brief_title>Collagen Scaffolds Loaded With HUCMSCs Improvement Erectile Function Men With Diabetes</brief_title>
	<detailed_description>Intracavernous transplantation stem cell show improve erectile function preclinical study . However , inadequate cell home damage site limited function . The investigator explore effect HUCMSC improve erectile function diabetic men , whether collagen scaffold contribute long-term cell retention corpus cavernous improves erectile function diabetic men .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>1. type 1 2 diabetes , blood glucose control well , effective oral PDE5i ; 2. consistent partner willing engage sexual activity twice per month study ; 3. male age 2065 year ; 4 . IIEF5 score 16 ; 5. penile arterial insufficiency venous leakage ( doppler ) : PSV &lt; 25 cm/sec , PSV &gt; 25 cm/sec , EDV &gt; 5cm/sec , RI &lt; 0 , 75 ; 6 . HbA1c 6.5 % 10 % ; 7. physical examination abnormality ; 8. willing consent participate study followup ; 9. willing limit alcohol intake eliminate use recreational drug sexual encounter . 1. severe cardiovascular disease ( angina , arrhythmia , cardiac failure , stroke ) , kidney failure , respiratory failure ; history malignancy ; 2. positive Human Immunodeficiency Virus ( HIV ) , Hepatitis B Virus ( HBV ) , Hepatitis C Virus ( HCV ) syphilis test ; 3 . Testosterone level le 200ng/dl ; 4. serum AST/ALT &gt; 3*upper limit normal creatinine &gt; 1.5*upper limit normal ; 5 . HbA1c exhibit great 10 % ; 6. investigator judgment , clinical significance penis abnormality , receive penile prosthesis implantation surgery ; 7. patient partner try conceive trial period ; 8. exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study ; 9. unwilling and/or able give write informed consent .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>erectile dysfunction</keyword>
	<keyword>stem cell</keyword>
	<keyword>collagen scaffold</keyword>
</DOC>